Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  4,777 results for ""Rheumatic Diseases drug therapy""

Your Filters

Content Provider : MEDLINE Filter by : Subject Phrase
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Comparable clinical advantages identification of three formulae on rheumatic disease using a modular-based network proximity approach.

  • Authors : Zong W; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.; Tian S

Subjects: Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/pharmacology ; Rheumatic Diseases*/Rheumatic Diseases*/Rheumatic Diseases*/drug therapy; Humans

  • Source: Journal of ethnopharmacology [J Ethnopharmacol] 2025 Jan 30; Vol. 337 (Pt 1), pp. 118764. Date of Electronic Publication: 2024 Aug 30.Publisher: Elsevier Sequoia Country of Publication: Ireland NLM ID: 7903310 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Trajectories of biologic drug use before, during and after pregnancy: an Italian cohort study from the VALORE project.

  • Authors : Lopes S; Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.; Servadio M

Subjects: Biological Products*/Biological Products*/Biological Products*/therapeutic use ; Biological Products*/Biological Products*/Biological Products*/adverse effects ; Pregnancy Complications*/Pregnancy Complications*/Pregnancy Complications*/drug therapy

  • Source: Expert opinion on biological therapy [Expert Opin Biol Ther] 2025 Jan; Vol. 25 (1), pp. 119-131. Date of Electronic Publication: 2024 Dec 21.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101125414 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Long-Term Mortality Following SARS-CoV-2 Infection in Rural Versus Urban Dwellers With Autoimmune or Inflammatory Rheumatic Disease: A Retrospective Cohort Analysis From the National COVID Cohort Collaborative.

Subjects: COVID-19*/COVID-19*/COVID-19*/mortality ; Rheumatic Diseases*/Rheumatic Diseases*/Rheumatic Diseases*/mortality ; Rheumatic Diseases*/Rheumatic Diseases*/Rheumatic Diseases*/drug therapy

  • Source: Arthritis care & research [Arthritis Care Res (Hoboken)] 2025 Jan; Vol. 77 (1), pp. 143-155. Date of Electronic Publication: 2024 Oct 16.Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101518086 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Use of platelet-rich plasma in rheumatic diseases.

  • Authors : Yessirkepov M; Department of Biology and Biochemistry, South Kazakhstan Medical Academy, Shymkent, Kazakhstan.; Fedorchenko Y

Subjects: Platelet-Rich Plasma* ; Rheumatic Diseases*/Rheumatic Diseases*/Rheumatic Diseases*/therapy ; Rheumatic Diseases*/Rheumatic Diseases*/Rheumatic Diseases*/drug therapy

  • Source: Rheumatology international [Rheumatol Int] 2024 Dec 31; Vol. 45 (1), pp. 13. Date of Electronic Publication: 2024 Dec 31.Publisher: Springer International Country of Publication: Germany NLM ID: 8206885 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Risk factors for adverse drug reactions to sulfamethoxazole-trimethoprim prophylaxis in patients with rheumatic and musculoskeletal diseases.

  • Authors : Hiramoto K; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.; Akiyama M

Subjects: Musculoskeletal Diseases*/Musculoskeletal Diseases*/Musculoskeletal Diseases*/chemically induced ; Musculoskeletal Diseases*/Musculoskeletal Diseases*/Musculoskeletal Diseases*/epidemiology ; Rheumatic Diseases*/Rheumatic Diseases*/Rheumatic Diseases*/drug therapy

  • Source: Modern rheumatology [Mod Rheumatol] 2024 Dec 25; Vol. 35 (1), pp. 94-101.Publisher: Oxford University Press Country of Publication: England NLM ID: 100959226 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Rationale for phosphodiesterase-4 inhibition as a treatment strategy for interstitial lung diseases associated with rheumatic diseases.

  • Authors : Aringer M; University Medical Center and Faculty of Medicine, TU Dresden, Dresden, Germany .; Distler O

Subjects: Cyclic Nucleotide Phosphodiesterases, Type 4*/Cyclic Nucleotide Phosphodiesterases, Type 4*/Cyclic Nucleotide Phosphodiesterases, Type 4*/metabolism ; Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/drug therapy ; Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/immunology

  • Source: RMD open [RMD Open] 2024 Dec 23; Vol. 10 (4). Date of Electronic Publication: 2024 Dec 23.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Influenza knowledge and barriers to vaccination in immunosuppressed patients in the pediatric rheumatology clinic.

  • Authors : Harris JG; Department of Pediatrics, Children's Mercy Kansas City, 2401 Gillham Road, Kansas City, MO, 64108, USA. .; University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA. .

Subjects: Influenza, Human*/Influenza, Human*/Influenza, Human*/prevention & control ; Immunocompromised Host*/Immunocompromised Host*/Immunocompromised Host*/immunology ; Influenza Vaccines*

  • Source: Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2024 Dec 18; Vol. 22 (1), pp. 104. Date of Electronic Publication: 2024 Dec 18.Publisher: BioMed Central Country of Publication: England NLM ID: 101248897 Publication Model: Electronic Cited Medium: Internet ISSN: 1546-0096

Record details

Read More Add to Saved list
×
Academic Journal

Clinical characteristics and prognostic factors of COVID-19 in rheumatic patients and their family members: a retrospective study.

  • Authors : Fan Y; Department of Rheumatism and Immunity, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.; National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.

Subjects: COVID-19*/COVID-19*/COVID-19*/complications ; Rheumatic Diseases*/Rheumatic Diseases*/Rheumatic Diseases*/drug therapy ; SARS-CoV-2*

  • Source: Frontiers in immunology [Front Immunol] 2024 Dec 16; Vol. 15, pp. 1439242. Date of Electronic Publication: 2024 Dec 16 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

The choice of treatment and the motivations behind it impact clinical outcomes among patients with adequate control of their rheumatic disease: A real-life study.

  • Authors : Contreras-Yáñez I; Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador-Zubirán (INCMyN-SZ), Mexico City, Mexico.; Guaracha-Basáñez GA

Subjects: Rheumatic Diseases*/Rheumatic Diseases*/Rheumatic Diseases*/drug therapy ; Rheumatic Diseases*/Rheumatic Diseases*/Rheumatic Diseases*/psychology ; Motivation*

  • Source: PloS one [PLoS One] 2024 Dec 12; Vol. 19 (12), pp. e0315478. Date of Electronic Publication: 2024 Dec 12 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Safety, efficacy, and immunogenicity of SARS-CoV-2 mRNA vaccination in children and adult patients with rheumatic diseases: a comprehensive literature review.

  • Authors : Dhanasekaran P; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. .; Karasu BT

Subjects: Rheumatic Diseases*/Rheumatic Diseases*/Rheumatic Diseases*/immunology ; Rheumatic Diseases*/Rheumatic Diseases*/Rheumatic Diseases*/drug therapy ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Rheumatology international [Rheumatol Int] 2024 Dec; Vol. 44 (12), pp. 2757-2794. Date of Electronic Publication: 2024 Nov 22.Publisher: Springer International Country of Publication: Germany NLM ID: 8206885 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  4,777 results for ""Rheumatic Diseases drug therapy""